Personalized cancer therapy one step closer to realityJune 17th, 2008 - 6:11 pm ICT by ANI
Washington, June 17 (ANI): Combining new molecular imaging techniques with targeted therapy may give cancer patients a more individualized treatment that can increase the effectiveness of therapies and minimize treatment discomfort.
In traditional radioimmunoimaging (RAII), radioisotopes are linked directly to antibodies and are delivered together to tumour targets.
In the targeted therapy a bispecific monoclonal antibody (bsMAb), with one arm that recognizes a tumour-associated antigen and another arm that recognizes a peptide carrying an imaging agent, is given as a first injection
“This study demonstrates the advantages of pretargetingan alternative strategy that uses a ‘two-step’ approach to the delivery of radioisotopeswhen applied to the imaging of tumours using a combination of radioisotope and antibody or RAII,” said Otto Boerman, professor in the department of nuclear medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands, and lead researcher of this study.
During the study, high specific uptake was obtained in human colon cancer cells transplanted in mice, resulting in very high tumour-to-blood and tumour-to-kidney ratios of radioisotope uptake.
Additionally, PET/CT imaging of mice pretargeted with the bispecific antibody 16 hours earlier revealed excellent high-contrast images of CEA-expressing tumours within one hour after injection.
The major attribute of pretargeting is that the same bsMAb can be used for diagnostic imaging and therapy,” said Boerman.
“When the imaging component of a pretargeting agent is used in concert with the therapeutic component, it permits the selection of a patient population that over-expresses a particular antigen, thus increasing these pre-screened patients’ probability of responding to the therapeutic.”
“The prescreening of patients afforded by pretargeting prior to therapy represents a potential major advancement in the management of neoplastic diseases, Boerman added.
The study was presented at SNM’s 55th Annual Meeting. (ANI)
- Pre-targeting approach may lead to personalised cancer therapies - Oct 05, 2009
- 'Bacterial rope, DNA chips to shape Indian biotech scene' - Sep 04, 2012
- Scientists develop novel tumour busting technique - Dec 07, 2011
- New 'Nanobody' agents help identify patients who will benefit from breast cancer drugs - Apr 12, 2011
- New antibody shows promising results in spinal cord injury - Aug 30, 2012
- 'Allergies linked to lower risk of brain tumours' - Aug 06, 2012
- Why PSA levels reflect prostate cancer progression - Jan 14, 2011
- Targeted photodynamic therapy offers hope for skin cancer patients - Apr 12, 2011
- 'Exciting breakthrough' offers hope to arthritis sufferers - Apr 22, 2010
- Groundbreaking technology to detect Alzheimer's developed - Jan 07, 2011
- Silica cages help anti-cancer antibodies prevent tumour growth in mice - May 22, 2010
- Tool for predicting local recurrence in lung cancer patients identified - Dec 07, 2010
- New 'nanodrug' can attack breast cancer cells from the inside out - Mar 30, 2011
- Novel gene therapy for cancer pain proves successful in small trial - Apr 12, 2011
- Indian-origin scientist's finding offers hope for advanced cancer patients - Apr 06, 2011
Tags: bispecific antibody, boerman, cancer patients, cancer therapy, colon cancer, colon cancer cells, contrast images, ct imaging, human colon, medical center nijmegen, molecular imaging, neoplastic diseases, nijmegen netherlands, nuclear medicine, patient population, pet ct, radioisotope, radioisotopes, step approach, university nijmegen